Adam Lezack serves as Executive at Beta Bionics, Inc., where they oversee executive responsibilities. Since joining the company, Adam Lezack has executed 5 insider transactions totaling $79.3K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 13, 2026 involved receiving (via award) 3,997 shares valued at $0.
Adam Lezack currently holds 12,432 shares of Beta Bionics, Inc. (BBNX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Adam Lezack has been a net seller of BBNX stock. They have purchased $0 and sold $79.3K worth of shares.
Adam Lezack's most recent insider trade was on Jan 13, 2026, when they sold 3,997 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $29.91 |
| Discretionary |
| Dec 1, 2025 | BBNX | $26.6K | Sale | 906 | $29.35 | Discretionary |
| Oct 31, 2025 | BBNX | $1.1K | Sale | 38 | $27.70 | Discretionary |
| Oct 31, 2025 | BBNX | $36.7K | Sale | 1,368 | $26.85 | Discretionary |